58 results
-
List item
National expert: Antonio Clavenna, European Medicines Agency (updated)
- Declaration of interests - 80.51 KB | PDF
- Curriculum Vitae - 29.74 KB | PDF
Ospedaliera "Ospedale Maggiore" of Crema, Italy. 2.11 Committee … -
List item
National expert: Emilio Perucca, Italian Medicines Agency (updated)
- Declaration of interests - 85.84 KB | PDF
- Curriculum Vitae - 116.29 KB | PDF
CRISTALLO, L., DE PASCALE, V., CREMA, A., CRAVERI, F., PERUCCA … BAMONTE, F., CRAVERI, F., CREMA, A., PERUCCA, E. and TEGGIA … POLONI, M., FRIGO, G.M. and CREMA, A. Pharmacokinetics of phenytoin … -
List item
National expert: Raffaella Sardelli, Italian Medicines Agency (updated)
- Declaration of interests - 80.05 KB | PDF
- Curriculum Vitae - 22.93 KB | PDF
quot;Contaminazione da alluminio in soluzioni di albumina umana: un monitoraggio … dell'attivatore della precallicreina in soluzioni di albumina umana" (Abs … -
List item
National expert: Eraldo Donnarumma, Italian Medicines Agency (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 17.98 KB | PDF
PANORAMI E PERCORSI) "Doping: soluzione o inganno chimico? (BIF n.4/2006 … -
List item
National expert: Victor Mangas Sanjuan, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 79.81 KB | PDF
- Curriculum Vitae - 34.19 KB | PDF
Belles-Medall MD, Garcia-Cremades M, Ferrando-Piqueres R, Mangas-Sanjuan … -
List item
National expert: Paola Minghetti, Italian Medicines Agency (updated)
- Declaration of interests - 81.41 KB | PDF
- Curriculum Vitae - 62.13 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Lutetium (177Lu) chloride Billev (previously Illuzyce)
lutetium (177Lu) chloride, Radionuclide Imaging
Date of authorisation: 15/09/2022, Revision: 1, Authorised, Last updated: 08/12/2022 -
List item
National expert: Armando Magrelli, Italian Medicines Agency (updated)
- Declaration of interests - 79.81 KB | PDF
- Curriculum Vitae - 29.06 KB | PDF
Agency http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000049.jsp&mid=WC0b01ac05800229b9 http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000094.jsp&mid=WC0b01ac0580028c79 http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000094.jsp&mid=WC0b01ac0580028c79 http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000049.jsp&mid=WC0b01ac05800229b9 Con Soluzioni Con Srl (Italy) Main activities … -
List item
National expert: Marta Morado, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 80.28 KB | PDF
- Curriculum Vitae - 24.32 KB | PDF
Rosado S, Morado M, Vallejo-Cremades MT, Martinez A, Vargas-Nunez … -
List item
Human medicine European public assessment report (EPAR): Elebrato Ellipta
fluticasone furoate, umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 15/11/2017, Revision: 10, Authorised, Last updated: 22/11/2022 -
List item
Human medicine European public assessment report (EPAR): Trelegy Ellipta
fluticasone furoate, umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 15/11/2017, Revision: 9, Authorised, Last updated: 25/07/2022 -
List item
Human medicine European public assessment report (EPAR): Relvar Ellipta
fluticasone furoate, vilanterol, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 13/11/2013, Revision: 24, Authorised, Last updated: 02/02/2023 -
List item
Human medicine European public assessment report (EPAR): Ketoconazole HRA
Ketoconazole, Cushing Syndrome
Date of authorisation: 18/11/2014,,
,
, Revision: 10, Authorised, Last updated: 07/06/2021
-
List item
National expert: Maria Vidal Losada, European Medicines Agency (updated)
- Declaration of interests - 80.36 KB | PDF
- Curriculum Vitae - 41.76 KB | PDF
-
List item
Referral: Veterinary medicinal products containing N-methyl pyrrolidone as an excipient
Article 82
Status: Under evaluation, opinion/position date: 11/05/2022, Last updated: 14/09/2022 -
List item
Referral: Nimesulide
nimesulide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/12/2003, EC decision date: 26/04/2004, Last updated: 13/05/2004 -
List item
Referral: EMLA cream and associated names
lidocaine, prilocaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/09/2014, EC decision date: 28/11/2014, Last updated: 15/01/2015 -
List item
Referral: Piroxicam
piroxicam, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/06/2007, EC decision date: 07/09/2007, Last updated: 31/01/2008 -
List item
Referral: Closamectin Pour-on Solution and associated names
ivermectin, closantel, Article 78
Status: European Commission final decision, opinion/position date: 08/10/2015, EC decision date: 22/03/2016, Last updated: 31/05/2016 -
List item
Referral: Fiprex
fipronil, Article 33
Status: European Commission final decision, opinion/position date: 09/04/2014, EC decision date: 14/07/2014, Last updated: 14/08/2014 -
List item
Referral: Tylosin injection for mastitis
tylosin, Article 35
Status: European Commission final decision, opinion/position date: 16/03/2017, EC decision date: 10/07/2017, Last updated: 31/07/2017 -
List item
Referral: Baytril injectable and generics
enrofloxacin, Article 35
Status: European Commission final decision, opinion/position date: 09/04/2014, EC decision date: 01/09/2014, Last updated: 10/12/2014 -
List item
Referral: Moxidectin-containing veterinary medicines used in cattle, sheep and horses
moxidectin, associated names: See annex I, Article 35
Status: European Commission final decision, opinion/position date: 11/05/2017, Last updated: 24/10/2017 -
List item
Referral: Injectable veterinary medicinal products containing vitamin A for use in food producing species
Vitamin A (retinol and its esters), Article 35
Status: European Commission final decision, opinion/position date: 12/05/2021, EC decision date: 18/08/2021, Last updated: 27/09/2021 -
List item
Referral: Veterinary medicinal products containing toltrazuril to be administered orally to chickens
toltrazuril, Article 35
Status: European Commission final decision, opinion/position date: 14/07/2022, EC decision date: 09/11/2022, Last updated: 14/12/2022